Nat. Rev. Endocrinol. doi: /nrendo

Slides:

Advertisements

Similar presentations

Phospholipid A phospholipid is a type of lipid used in the cells of living things.

Advertisements

A B C Embryo L4 larvae AL DR TAG PC

Intermyocellular fat depot

Mechanisms of diabetic neuropathy.

Figure 2 Pathophysiology of hyperglycaemia in T2DM

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 4 Amino acid structure of short-acting and long-acting insulins

Figure 3 Metabolism in homeostatic chondrocytes

Figure 2 Proinflammatory mechanisms in CKD

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Pathophysiological aspects of insulin

Obesity, inflammation, and liver cancer

Figure 5 Sterol regulatory element-binding

Figure 1 Monogenic forms of diabetes mellitus

Figure 2 Candidate signalling pathways of irisin in myocytess

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 3 Metabolic configurations of M1 and M2 macrophages

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Metabolic reprogramming of immune cells upon activation

Figure 1 Metabolic adaptations of cancer cells

Nat. Rev. Endocrinol. doi: /nrendo

Figure 3 ER stress and hepatic steatosis: a vicious cycle

Figure 3 Polysaccharides from plants and mushrooms

Figure 3 Modular assembly of the GnRH neuronal network

Figure 1 Control of hepatic gluconeogenesis

Figure 1 Challenges and opportunities of using omics in EDC research

Figure 3 Biosynthetic pathway of plasmalogens

Figure 2 Molecular mechanisms of the antidiabetic

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Pharmacokinetic action profiles of rapid-acting insulins

Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.

Figure 2 Organ crosstalk in the pathophysiology

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Volume 62, Issue 1, Pages (January 2015)

Figure 1 The insulin signalling pathway

Nat. Rev. Endocrinol. doi: /nrendo

Autophagy: A Sweet Process in Diabetes

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Regulation of hepatic glucose metabolism by the gut, brain and liver Figure 1 | Regulation of hepatic glucose metabolism by the gut, brain and.

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Exosomes mediate the systemic benefits of endurance exercise

The Origins and Drivers of Insulin Resistance

Nat. Rev. Endocrinol. doi: /nrendo

Figure 5 Ether-containing lipid biosynthesis pathways

Figure 1 Sites of action of glucose-lowering agents

Figure 2 Lipid metabolism and metabolism-disrupting chemicals.

Figure 3 Regulation of insulin sensitivity by innate immune cells

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Pathophysiological heterogeneity in patients with PCOS

Figure 1 Glycerophospholipid classes and subclasses

A Ceramide-Centric View of Insulin Resistance

NASH animal models: Are we there yet?

Discrimination between Two Endocannabinoids

Figure 1 NAFLD pathogenesis

Worked Example 23.1 Identifying Lipid Families

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Initiators of obesity-associated inflammation in adipocytes

Figure 1 Exercise enhances insulin sensitivity

Fig. 1. Lipid analysis.(a) HP-TLC analysis of DIMs of tobacco pollen tubes, using increasing detergent/protein ratios. Lipid analysis.(a) HP-TLC analysis.

Fig. 3. Comparison of our hypothesis and “adipose tissue hypoxia” theory. The hypothesis of “adipose tissue hypoxia” explains that hypoxia occurs in enlarged.

Lipid mass spectrometry analysis of WT, tgl3Δ and vps4Δ mutant cells.

C16:0-Ceramide Signals Insulin Resistance

Figure 1 Thyroid hormone effects on hepatic lipid metabolism

Volume 18, Issue 3, Pages (January 2017)

Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.169 Figure 5 Feedback loops between lipid metabolism and insulin resistance Figure 5 | Feedback loops between lipid metabolism and insulin resistance. Diet and activity can lead to obesity, which can lead to increased levels of fatty acids. These factors feed into multiple lipid metabolic pathways, which results in dysfunctional lipid metabolism and initiates multiple feedback loops through mitochondrial dysfunction, reactive oxygen species (ROS) production and inflammation. DAG, diacylglycerol, DHAP, dihydroxyacetone phosphate; FFA, free fatty acids; PC, phosphatidylcholine; PE, phosphatidylethanolamine. Meikle, P. J. & Summers, S. A. (2016) Sphingolipids and phospholipids in insulin resistance and related metabolic disorders Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.169